Genetic ablation of arginase 1 in macrophages and neutrophils enhances clearance of an arthritogenic alphavirus

Journal of Immunology

Volumn 189, Issue 8, 2012, Pages 4047-4059

  Stoermer, Kristina A ^a   Burrack, Adam ^a   Oko, Lauren ^a   Montgomery, Stephanie A ^b   Borst, Luke B ^b   Gill, Ronald G ^a   Morrison, Thomas E ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGINASE 1; CELL MARKER; PROTEIN CHI3L3; PROTEIN FIZZ1; PROTEIN RELM ALPHA; PROTEIN YM1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL STRAIN BHK; CHIKUNGUNYA ALPHAVIRUS; CHIKUNGUNYA ALPHAVIRUS INFECTION; CONTROLLED STUDY; DISEASE SEVERITY; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; GENE EXPRESSION; GENETIC ABLATION; GENETIC PROCEDURES; HISTOLOGY; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MOUSE; MUSCULOSKELETAL INJURY; NEUTROPHIL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA VIRUS INFECTION; ROSS RIVER ALPHA VIRUS; ROSS RIVER ALPHA VIRUS INFECTION; VIRAL CLEARANCE; VIRUS STRAIN; WESTERN BLOTTING; WOUND HEALING;

ALPHAVIRUS INFECTIONS; ANIMALS; ARGINASE; CELL LINE; CHIKUNGUNYA VIRUS; CRICETINAE; GENE DELETION; HUMANS; INFLAMMATION; MACROPHAGES; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, TRANSGENIC; MYELOID CELLS; NEUTROPHILS; ROSS RIVER VIRUS; UP-REGULATION; VIRAL LOAD;

EID: 84867289691     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1201240     Document Type: Article

References (90)

1. Powers, A. M., A. C. Brault, Y. Shirako, E. G. Strauss, W. Kang, J. H. Strauss, and S. C. Weaver. 2001. Evolutionary relationships and systematics of the alphaviruses. J. Virol. 75: 10118-10131. (Pubitemid 32948042)
2. Harley, D., A. Sleigh, and S. Ritchie. 2001. Ross River virus transmission, infection, and disease: a cross-disciplinary review. Clin. Microbiol. Rev. 14: 909-932, table of contents. (Pubitemid 32979635)
3. Williams, M. C., J. P. Woodall, and J. D. Gillett. 1965. O'nyong-Nyong fever: an epidemic virus diesease in East Africa. VII. Virus isolations from man and serological studies up to July 1961. Trans. R. Soc. Trop. Med. Hyg. 59: 186-197.
4. Weaver, S. C., and W. K. Reisen. 2010. Present and future arboviral threats. Antiviral Res. 85: 328-345.
5. Grandadam, M., V. Caro, S. Plumet, J. M. Thiberge, Y. Souarès, A. B. Failloux, H. J. Tolou, M. Budelot, D. Cosserat, I. Leparc-Goffart, and P. Desprès. 2011. Chikungunya virus, southeastern France. Emerg. Infect. Dis. 17: 910-913.
6. Rezza, G., L. Nicoletti, R. Angelini, R. Romi, A. C. Finarelli, M. Panning, P. Cordioli, C. Fortuna, S. Boros, F. Magurano, et al; CHIKV study group. 2007. Infection with chikungunya virus in Italy: an outbreak in a temperate region. Lancet 370: 1840-1846. (Pubitemid 350180033)
7. ProMed-mail. Chikungunya: New Caledonia. ProMED-mail 2011 25 May: 20110525.1594. Accessed August 3, 2011.
8. Gibney, K. B., M. Fischer, H. E. Prince, L. D. Kramer, K. St George, O. L. Kosoy, J. J. Laven, and J. E. Staples. 2011. Chikungunya fever in the United States: a fifteen year review of cases. Clin. Infect. Dis. 52: e121-e126.
9. Watson, R. 2007. Europe witnesses first local transmission of chikungunya fever in Italy. BMJ 335: 532-533.
10. Oliva, O., J. L. San Martin, and R. S. Nasci. 2011. Guidelines for Preparedness and Response for Chikungunya Virus Introduction in the Americas. Pan American Health Organization, Washington, D.C.
11. Pinheiro, F. P., R. B. Freitas, J. F. Travassos da Rosa, Y. B. Gabbay, W. A. Mello, and J. W. LeDuc. 1981. An outbreak of Mayaro virus disease in Belterra, Brazil. I. Clinical and virological findings. Am. J. Trop. Med. Hyg. 30: 674-681. (Pubitemid 11074949)
12. Staples, J. E., R. F. Breiman, and A. M. Powers. 2009. Chikungunya fever: an epidemiological review of a re-emerging infectious disease. Clin. Infect. Dis. 49: 942-948.
13. Sissoko, D., D. Malvy, K. Ezzedine, P. Renault, F. Moscetti, M. Ledrans, and V. Pierre. 2009. Post-epidemic Chikungunya disease on Reunion Island: course of rheumatic manifestations and associated factors over a 15-month period. PLoS Negl. Trop. Dis. 3: e389.
14. Borgherini, G., P. Poubeau, A. Jossaume, A. Gouix, L. Cotte, A. Michault, C. Arvin-Berod, and F. Paganin. 2008. Persistent arthralgia associated with chikungunya virus: a study of 88 adult patients on reunion island. Clin. Infect. Dis. 47: 469-475.
15. Brighton, S. W., O.W. Prozesky, and A. L. de la Harpe. 1983. Chikungunya virus infection. A retrospective study of 107 cases. S. Afr. Med. J. 63: 313-315. (Pubitemid 13121054)
16. Larrieu, S., N. Pouderoux, T. Pistone, L. Filleul, M. C. Receveur, D. Sissoko, K. Ezzedine, and D. Malvy. 2010. Factors associated with persistence of arthralgia among Chikungunya virus-infected travellers: report of 42 French cases. J. Clin. Virol. 47: 85-88.
17. Simon, F., P. Parola, M. Grandadam, S. Fourcade, M. Oliver, P. Brouqui, P. Hance, P. Kraemer, A. Ali Mohamed, X. de Lamballerie, et al. 2007. Chikungunya infection: an emerging rheumatism among travelers returned from Indian Ocean islands. Report of 47 cases. Medicine (Baltimore) 86: 123-137. (Pubitemid 46787967)
18. Kularatne, S. A., S. C. Weerasinghe, C. Gihan, S. Wickramasinghe, S. Dharmarathne, A. Abeyrathna, and T. Jayalath. 2012. Epidemiology, clinical manifestations, and long-term outcomes of a major outbreak of chikungunya in a hamlet in Sri Lanka, in 2007: a longitudinal cohort study. J. Trop. Med. 2012: 639178.
19. Harley, D., D. Bossingham, D. M. Purdie, N. Pandeya, and A. C. Sleigh. 2002. Ross River virus disease in tropical Queensland: evolution of rheumatic manifestations in an inception cohort followed for six months. Med. J. Aust. 177: 352-355. (Pubitemid 36104279)
20. Condon, R. J., and I. L. Rouse. 1995. Acute symptoms and sequelae of Ross River virus infection in South-Western Australia: a follow-up study. Clin. Diagn. Virol. 3: 273-284.
21. Mylonas, A. D., A. M. Brown, T. L. Carthew, B. McGrath, D. M. Purdie, N. Pandeya, P. C. Vecchio, L. G. Collins, I. D. Gardner, F. J. de Looze, et al. 2002. Natural history of Ross River virus-induced epidemic polyarthritis. Med. J. Aust. 177: 356-360. (Pubitemid 36104280)
22. Selden, S. M., and A. S. Cameron. 1996. Changing epidemiology of Ross River virus disease in South Australia. Med. J. Aust. 165: 313-317. (Pubitemid 26328898)
23. Westley-Wise, V. J., J. R. Beard, T. J. Sladden, T. M. Dunn, and J. Simpson. 1996. Ross River virus infection on the North Coast of New South Wales. Aust. N. Z. J. Public Health 20: 87-92. (Pubitemid 26192004)
24. Economopoulou, A., M. Dominguez, B. Helynck, D. Sissoko, O. Wichmann, P. Quenel, P. Germonneau, and I. Quatresous. 2009. Atypical Chikungunya virus infections: clinical manifestations, mortality and risk factors for severe disease during the 2005-2006 outbreak on Réunion. Epidemiol. Infect. 137: 534-541.
25. Pialoux, G., B. A. Gaüzère, S. Jauréguiberry, and M. Strobel. 2007. Chikungunya, an epidemic arbovirosis. Lancet Infect. Dis. 7: 319-327.
26. Morrison, T. E., R. J. Fraser, P. N. Smith, S. Mahalingam, and M. T. Heise. 2007. Complement contributes to inflammatory tissue destruction in a mouse model of Ross River virus-induced disease. J. Virol. 81: 5132-5143. (Pubitemid 46744424)
27. Morrison, T. E., L. Oko, S. A. Montgomery, A. C. Whitmore, A. R. Lotstein, B. M. Gunn, S. A. Elmore, and M. T. Heise. 2011. A mouse model of chikungunya virus-induced musculoskeletal inflammatory disease: evidence of arthritis, tenosynovitis, myositis, and persistence. Am. J. Pathol. 178: 32-40.
28. Morrison, T. E., A. C.Whitmore, R. S. Shabman, B. A. Lidbury, S. Mahalingam, and M. T. Heise. 2006. Characterization of Ross River virus tropism and virus-induced inflammation in a mouse model of viral arthritis and myositis. J. Virol. 80: 737-749. (Pubitemid 43062886)
29. Hoarau, J. J., M. C. Jaffar Bandjee, P. Krejbich Trotot, T. Das, G. Li-Pat-Yuen, B. Dassa, M. Denizot, E. Guichard, A. Ribera, T. Henni, et al. 2010. Persistent chronic inflammation and infection by Chikungunya arthritogenic alphavirus in spite of a robust host immune response. J. Immunol. 184: 5914-5927.
30. Ozden, S., M. Huerre, J. P. Riviere, L. L. Coffey, P. V. Afonso, V. Mouly, J. de Monredon, J. C. Roger, M. El Amrani, J. L. Yvin, et al. 2007. Human muscle satellite cells as targets of Chikungunya virus infection. PLoS ONE 2: e527.
31. Labadie, K., T. Larcher, C. Joubert, A. Mannioui, B. Delache, P. Brochard, L. Guigand, L. Dubreil, P. Lebon, B. Verrier, et al. 2010. Chikungunya disease in nonhuman primates involves long-term viral persistence in macrophages. J. Clin. Invest. 120: 894-906.
32. Soden, M., H. Vasudevan, B. Roberts, R. Coelen, G. Hamlin, S. Vasudevan, and J. La Brooy. 2000. Detection of viral ribonucleic acid and histologic analysis of inflamed synovium in Ross River virus infection. Arthritis Rheum. 43: 365-369. (Pubitemid 30395745)
33. Fraser, J. R., A. L. Cunningham, B. J. Clarris, J. G. Aaskov, and R. Leach. 1981. Cytology of synovial effusions in epidemic polyarthritis. Aust. N. Z. J. Med. 11: 168-173. (Pubitemid 11079321)
34. Gordon, S., and P. R. Taylor. 2005. Monocyte and macrophage heterogeneity. Nat. Rev. Immunol. 5: 953-964. (Pubitemid 41746764)
35. Murray, P. J., and T. A. Wynn. 2011. Protective and pathogenic functions of macrophage subsets. Nat. Rev. Immunol. 11: 723-737.
36. Biswas, S. K., and A. Mantovani. 2010. Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nat. Immunol. 11: 889-896.
37. Loke, P., I. Gallagher, M. G. Nair, X. Zang, F. Brombacher, M. Mohrs, J. P. Allison, and J. E. Allen. 2007. Alternative activation is an innate response to injury that requires CD4+ T cells to be sustained during chronic infection. J. Immunol. 179: 3926-3936.
38. Duffield, J. S., S. J. Forbes, C. M. Constandinou, S. Clay, M. Partolina, S. Vuthoori, S. Wu, R. Lang, and J. P. Iredale. 2005. Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair. J. Clin. Invest. 115: 56-65. (Pubitemid 40385505)
39. Shechter, R., A. London, C. Varol, C. Raposo, M. Cusimano, G. Yovel, A. Rolls, M. Mack, S. Pluchino, G. Martino, et al. 2009. Infiltrating blood-derived macrophages are vital cells playing an anti-inflammatory role in recovery from spinal cord injury in mice. PLoS Med. 6: e1000113.
40. Nahrendorf, M., F. K. Swirski, E. Aikawa, L. Stangenberg, T. Wurdinger, J. L. Figueiredo, P. Libby, R. Weissleder, and M. J. Pittet. 2007. The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions. J. Exp. Med. 204: 3037-3047. (Pubitemid 350179569)
41. Ruffell, D., F. Mourkioti, A. Gambardella, P. Kirstetter, R. G. Lopez, N. Rosenthal, and C. Nerlov. 2009. A CREB-C/EBPbeta cascade induces M2 macrophage-specific gene expression and promotes muscle injury repair. Proc. Natl. Acad. Sci. USA 106: 17475-17480.
42. Villalta, S. A., B. Deng, C. Rinaldi, M. Wehling-Henricks, and J. G. Tidball. 2011. IFN-γ promotes muscle damage in the mdx mouse model of Duchenne muscular dystrophy by suppressing M2 macrophage activation and inhibiting muscle cell proliferation. J. Immunol. 187: 5419-5428.
43. Chen, F., Z. Liu, W. Wu, C. Rozo, S. Bowdridge, A. Millman, N. Van Rooijen, J. F. Urban, Jr., T. A. Wynn, and W. C. Gause. 2012. An essential role for TH2- type responses in limiting acute tissue damage during experimental helminth infection. Nat. Med. 18: 260-266.
44. Allen, J. E., and T. A. Wynn. 2011. Evolution of Th2 immunity: a rapid repair response to tissue destructive pathogens. PLoS Pathog. 7: e1002003.
45. Shirey, K. A., L. M. Pletneva, A. C. Puche, A. D. Keegan, G. A. Prince, J. C. Blanco, and S. N. Vogel. 2010. Control of RSV-induced lung injury by alternatively activated macrophages is IL-4R alpha-, TLR4-, and IFN-beta-dependent. Mucosal Immunol. 3: 291-300.
46. Morris, S. M., Jr. 2009. Recent advances in arginine metabolism: roles and regulation of the arginases. Br. J. Pharmacol. 157: 922-930.
47. Mantovani, A., S. Sozzani, M. Locati, P. Allavena, and A. Sica. 2002. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol. 23: 549-555. (Pubitemid 35223554)
48. Martinez, F. O., L. Helming, and S. Gordon. 2009. Alternative activation of macrophages: an immunologic functional perspective. Annu. Rev. Immunol. 27: 451-483.
49. Bronte, V., and P. Zanovello. 2005. Regulation of immune responses by L-arginine metabolism. Nat. Rev. Immunol. 5: 641-654. (Pubitemid 41113195)
50. Munder, M. 2009. Arginase: an emerging key player in the mammalian immune system. Br. J. Pharmacol. 158: 638-651.
51. Rodríguez, P. C., and A. C. Ochoa. 2008. Arginine regulation by myeloid derived suppressor cells and tolerance in cancer: mechanisms and therapeutic perspectives. Immunol. Rev. 222: 180-191.
52. El Kasmi, K. C., J. E. Qualls, J. T. Pesce, A. M. Smith, R. W. Thompson, M. Henao-Tamayo, R. J. Basaraba, T. König, U. Schleicher, M. S. Koo, et al. 2008. Toll-like receptor-induced arginase 1 in macrophages thwarts effective immunity against intracellular pathogens. Nat. Immunol. 9: 1399-1406.
53. Pesce, J. T., T. R. Ramalingam, M. M. Mentink-Kane, M. S. Wilson, K. C. El Kasmi, A. M. Smith, R. W. Thompson, A. W. Cheever, P. J. Murray, and T. A. Wynn. 2009. Arginase-1-expressing macrophages suppress Th2 cytokinedriven inflammation and fibrosis. PLoS Pathog. 5: e1000371.
54. Rodriguez, P. C., D. G. Quiceno, J. Zabaleta, B. Ortiz, A. H. Zea, M. B. Piazuelo, A. Delgado, P. Correa, J. Brayer, E. M. Sotomayor, et al. 2004. Arginase I production in the tumor microenvironment by mature myeloid cells inhibits Tcell receptor expression and antigen-specific T-cell responses. Cancer Res. 64: 5839-5849. (Pubitemid 39095585)
55. Zea, A. H., P. C. Rodriguez, M. B. Atkins, C. Hernandez, S. Signoretti, J. Zabaleta, D. McDermott, D. Quiceno, A. Youmans, A. O'Neill, et al. 2005. Arginase-producing myeloid suppressor cells in renal cell carcinoma patients: a mechanism of tumor evasion. Cancer Res. 65: 3044-3048. (Pubitemid 40524582)
56. Bronte, V., P. Serafini, C. De Santo, I. Marigo, V. Tosello, A. Mazzoni, D. M. Segal, C. Staib, M. Lowel, G. Sutter, et al. 2003. IL-4-induced arginase 1 suppresses alloreactive T cells in tumor-bearing mice. J. Immunol. 170: 270-278. (Pubitemid 36026149)
57. Gardner, J., I. Anraku, T. T. Le, T. Larcher, L. Major, P. Roques, W. A. Schroder, S. Higgs, and A. Suhrbier. 2010. Chikungunya virus arthritis in adult wild-type mice. J. Virol. 84: 8021-8032.
58. Lidbury, B. A., N. E. Rulli, A. Suhrbier, P. N. Smith, S. R. McColl, A. L. Cunningham, A. Tarkowski, N. van Rooijen, R. J. Fraser, and S. Mahalingam. 2008. Macrophage-derived proinflammatory factors contribute to the development of arthritis and myositis after infection with an arthrogenic alphavirus. J. Infect. Dis. 197: 1585-1593. (Pubitemid 351706489)
59. Doherty, R. l., R. H. Whitehead, B. M. Gorman, and A. K. O'Gower. 1963. The isolation of a third group A arbovirus in Australia, with preliminary observations on its realtionships to epidemic polyarthritis. Aust. J. Sci. 26: 183-184.
60. Kuhn, R. J., H. G. Niesters, Z. Hong, and J. H. Strauss. 1991. Infectious RNA transcripts from Ross River virus cDNA clones and the construction and characterization of defined chimeras with Sindbis virus. Virology 182: 430-441.
61. Jupille, H. J., L. Oko, K. A. Stoermer, M. T. Heise, S. Mahalingam, B. M. Gunn, and T. E. Morrison. 2011. Mutations in nsP1 and PE2 are critical determinants of Ross River virus-induced musculoskeletal inflammatory disease in a mouse model. Virology 410: 216-227.
62. Clausen, B. E., C. Burkhardt, W. Reith, R. Renkawitz, and I. Förster. 1999. Conditional gene targeting in macrophages and granulocytes using LysMcre mice. Transgenic Res. 8: 265-277. (Pubitemid 29523965)
63. Livak, K. J., and T. D. Schmittgen. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(2Delta Delta C(T)) Method. Methods 25: 402-408. (Pubitemid 34164012)
64. Nicolls, M. R., M. Coulombe, J. Beilke, H. C. Gelhaus, and R. G. Gill. 2002. CD4-dependent generation of dominant transplantation tolerance induced by simultaneous perturbation of CD154 and LFA-1 pathways. J. Immunol. 169: 4831-4839. (Pubitemid 35217146)
65. Gordon, S., and F. O. Martinez. 2010. Alternative activation of macrophages: mechanism and functions. Immunity 32: 593-604.
66. Munder, M., K. Eichmann, and M. Modolell. 1998. Alternative metabolic states in murine macrophages reflected by the nitric oxide synthase/arginase balance: competitive regulation by CD4+ T cells correlates with Th1/Th2 phenotype. J. Immunol. 160: 5347-5354. (Pubitemid 28267823)
67. Modolell, M., B. S. Choi, R. O. Ryan, M. Hancock, R. G. Titus, T. Abebe, A. Hailu, I. Müller, M. E. Rogers, C. R. Bangham, et al. 2009. Local suppression of T cell responses by arginase-induced L-arginine depletion in nonhealing leishmaniasis. PLoS Negl. Trop. Dis. 3: e480.
68. Cotter, M. J., and D. A. Muruve. 2006. Isolation of neutrophils from mouse liver: A novel method to study effector leukocytes during inflammation. J. Immunol. Methods 312: 68-78. (Pubitemid 43795990)
69. Morrison, T. E., J. D. Simmons, and M. T. Heise. 2008. Complement receptor 3 promotes severe ross river virus-induced disease. J. Virol. 82: 11263-11272.
70. Lidbury, B. A., C. Simeonovic, G. E. Maxwell, I. D. Marshall, and A. J. Hapel. 2000. Macrophage-induced muscle pathology results in morbidity and mortality for Ross River virus-infected mice. J. Infect. Dis. 181: 27-34. (Pubitemid 30049029)
71. Hazelton, R. A., C. Hughes, and J. G. Aaskov. 1985. The inflammatory response in the synovium of a patient with Ross River arbovirus infection. Aust. N. Z. J. Med. 15: 336-339. (Pubitemid 15020610)
72. Seay, A. R., D. E. Griffin, and R. T. Johnson. 1981. Experimental viral polymyositis: age dependency and immune responses to Ross River virus infection in mice. Neurology 31: 656-660.
73. Wynn, T. A. 2004. Fibrotic disease and the T(H)1/T(H)2 paradigm. Nat. Rev. Immunol. 4: 583-594.
74. Rulli, N. E., A. Guglielmotti, G. Mangano, M. S. Rolph, C. Apicella, A. Zaid, A. Suhrbier, and S. Mahalingam. 2009. Amelioration of alphavirus-induced arthritis and myositis in a mouse model by treatment with bindarit, an inhibitor of monocyte chemotactic proteins. Arthritis Rheum. 60: 2513-2523.
75. Rulli, N. E., M. S. Rolph, A. Srikiatkhachorn, S. Anantapreecha, A. Guglielmotti, and S. Mahalingam. 2011. Protection from arthritis and myositis in a mouse model of acute chikungunya virus disease by bindarit, an inhibitor of monocyte chemotactic protein-1 synthesis. J. Infect. Dis. 204: 1026-1030.
76. Porta, C., M. Rimoldi, G. Raes, L. Brys, P. Ghezzi, D. Di Liberto, F. Dieli, S. Ghisletti, G. Natoli, P. De Baetselier, et al. 2009. Tolerance and M2 (alternative) macrophage polarization are related processes orchestrated by p50 nuclear factor kappaB. Proc. Natl. Acad. Sci. USA 106: 14978-14983.
77. Sandler, N. G., M. M. Mentink-Kane, A. W. Cheever, and T. A. Wynn. 2003. Global gene expression profiles during acute pathogen-induced pulmonary inflammation reveal divergent roles for Th1 and Th2 responses in tissue repair. J. Immunol. 171: 3655-3667. (Pubitemid 37254569)
78. Satoh, T., O. Takeuchi, A. Vandenbon, K. Yasuda, Y. Tanaka, Y. Kumagai, T. Miyake, K. Matsushita, T. Okazaki, T. Saitoh, et al. 2010. The Jmjd3-Irf4 axis regulates M2 macrophage polarization and host responses against helminth infection. Nat. Immunol. 11: 936-944.
79. Qualls, J. E., G. Neale, A. M. Smith, M. S. Koo, A. A. DeFreitas, H. Zhang, G. Kaplan, S. S. Watowich, and P. J. Murray. 2010. Arginine usage in mycobacteria-infected macrophages depends on autocrine-paracrine cytokine signaling. Sci. Signal. 3: ra62.
80. Sharda, D. R., S. Yu, M. Ray, M. L. Squadrito, M. De Palma, T. A. Wynn, S. M. Morris, Jr., and P. A. Hankey. 2011. Regulation of macrophage arginase expression and tumor growth by the Ron receptor tyrosine kinase. J. Immunol. 187: 2181-2192.
81. Cuervo, H., N. A. Guerrero, S. Carbajosa, A. Beschin, P. De Baetselier, N. Gironès, and M. Fresno. 2011. Myeloid-derived suppressor cells infiltrate the heart in acute Trypanosoma cruzi infection. J. Immunol. 187: 2656-2665.
82. Gabrilovich, D. I., and S. Nagaraj. 2009. Myeloid-derived suppressor cells as regulators of the immune system. Nat. Rev. Immunol. 9: 162-174.
83. Binder, G. K., and D. E. Griffin. 2001. Interferon-gamma-mediated site-specific clearance of alphavirus from CNS neurons. Science 293: 303-306. (Pubitemid 32694747)
84. Levine, B., J. M. Hardwick, B. D. Trapp, T. O. Crawford, R. C. Bollinger, and D. E. Griffin. 1991. Antibody-mediated clearance of alphavirus infection from neurons. Science 254: 856-860. (Pubitemid 21917413)
85. Levine, B., and D. E. Griffin. 1992. Persistence of viral RNA in mouse brains after recovery from acute alphavirus encephalitis. J. Virol. 66: 6429-6435.
86. Brooke, C. B., D. J. Deming, A. C. Whitmore, L. J. White, and R. E. Johnston. 2010. T cells facilitate recovery from Venezuelan equine encephalitis virus-induced encephalomyelitis in the absence of antibody. J. Virol. 84: 4556-4568.
87. Rodriguez, P. C., D. G. Quiceno, and A. C. Ochoa. 2007. L-arginine availability regulates T-lymphocyte cell-cycle progression. Blood 109: 1568-1573. (Pubitemid 46239590)
88. Barton, E. R., L. Morris, M. Kawana, L. T. Bish, and T. Toursel. 2005. Systemic administration of L-arginine benefits mdx skeletal muscle function. Muscle Nerve 32: 751-760. (Pubitemid 41746263)
89. Voisin, V., C. Sébrié, S. Matecki, H. Yu, B. Gillet, M. Ramonatxo, M. Israël, and S. De la Porte. 2005. L-arginine improves dystrophic phenotype in mdx mice. Neurobiol. Dis. 20: 123-130.
90. Das, P., A. Lahiri, A. Lahiri, and D. Chakravortty. 2010. Modulation of the arginase pathway in the context of microbial pathogenesis: a metabolic enzyme moonlighting as an immune modulator. PLoS Pathog. 6: e1000899.